Reading this clinical breakthrough? See how real patients are applying these numbers in real life. Compare real-world patient outcomes, lab numbers, and doctor visit tips—100% free with a private @handle and zero login wall.
Click to Ask a Question or Post Your Experience ▾
Post to Gut, Labs & Supplements Space (15 Seconds • No Account or Email Required)
Or read existing discussions in Gut, Labs & Supplements Space →
Official NIH NLM MEDLINE / PubMed Citation • PMID: 42947512 • DOI: 10.4103/IJO.IJO_3296_25

Pars plana vitrectomy with silicone oil versus pars plana vitrectomy alone for postoperative endophthalmitis: A randomized controlled trial.

Indian journal of ophthalmology • 2026 Nov • Vol. 74 (11) : 1663-1669 • ISSN 1998-3689
Authors: Ehab Mohamed Elsayed Saad, Hazem Elbadry Mohammed Mohammed, Ehab Tharwat, Sayed Mostafa Elsayed Abdelhafeez, Ahmed Mohammed Sakr, Mohamed Gaber Okasha, Mohamed Abd Elmoamen Mohamed Saad Eldeen, Nehad Mohammed Yusef, Omar Hassan Salama Selim, Tamer Gamal Elsayed
Department of Ophthalmology, Faculty of Medicine, Benha University, Benha, Egypt.

Verbatim Formal Study Abstract

PURPOSE

The role of silicone oil (SO) tamponade in pars plana vitrectomy (PPV) for postoperative endophthalmitis remains controversial. This study compared outcomes of PPV with SO versus PPV alone in severe cases, incorporating intraocular cytokine profiling and regression analysis.

METHODS

In this prospective randomized controlled trial, 40 eyes with post-phacoemulsification postoperative endophthalmitis unresponsive to initial intravitreal antibiotics were randomized to PPV alone (n = 20) or PPV with 1000-cSt SO tamponade (n = 20). The primary outcome was change in best-corrected visual acuity (BCVA, logMAR) at 12 weeks. Secondary outcomes included recurrence of infection, retinal detachment (RD), and intraocular cytokine levels (interleukin [IL]-6, IL-8). Correlation and multivariate regression analyses were performed to identify predictors of final visual outcome.

RESULTS

Final BCVA improved more in the SO group (1.5 ± 0.3 logMAR) compared with the PPV-alone group (1.7 ± 0.4 logMAR), although this difference was not statistically significant (P = 0.289). Recurrence was observed in two eyes (10%) within the SO cohort compared to eight eyes (40%) in the PPV-alone cohort (P = 0.021). At 8 weeks, intraocular cytokine levels were markedly reduced in the SO group (IL-6: 142 pg/mL vs. 298 pg/mL, P = 0.018; IL-8: 84 pg/mL vs. 176 pg/mL, P = 0.024). In the PPV-alone group, 8-week IL-6 levels strongly correlated with final BCVA (r = 0.712, P = 0.006). Multivariate regression identified recurrence of infection (β = 0.31, P = 0.009) and 8-week IL-6 levels (β = 0.001, P = 0.003) as independent predictors of worse visual outcomes.

CONCLUSION

PPV with SO tamponade significantly reduces recurrent infection and intraocular inflammation in severe postoperative endophthalmitis, leading to trends toward improved visual outcomes. These benefits appear mediated by both anti-infective and anti-inflammatory mechanisms, supporting the use of SO in complex cases.

Publication Classification: Journal Article Randomized Controlled Trial
NLM MeSH Descriptors: Aged Female Humans Male Middle Aged Endophthalmitis Endotamponade Eye Infections, Bacterial Follow-Up Studies Phacoemulsification Postoperative Complications Prospective Studies Silicone Oils Treatment Outcome Visual Acuity Vitrectomy